Top

Published in:

01-08-2008 | Parkinson's Disease and Allied Conditions - Short Communication

Dopaminergic modulation of emotional memory in Parkinson’s disease

Authors: Thomas D. Hälbig, Ute A. Kopp, Franziska Wodarz, Joan C. Borod, Jean-Michel Gracies, Georg Ebersbach, Andreas Kupsch

Published in: Journal of Neural Transmission | Issue 8/2008

Abstract

The aim of this study was to assess the effect of dopaminergic treatment on emotional memory in patients with Parkinson’s disease (PD). We tested memory for emotional and neutral visual stimuli in ten non-demented PD patients on and off dopaminergic medication. Patients recalled significantly more emotional items during the off- than on-medication testing session. In contrast, treatment condition did not affect memory for neutral items. These findings demonstrate that emotional memory deficits observed in PD may result from dopaminergic treatment and suggest an involvement of dopaminergic neurotransmission in emotional processing.

Adolphs R (2002) Neural systems for recognizing emotion. Curr Opin Neurobiol 12:169–177PubMedCrossRef

Adolphs R, Schul R, Tranel D (1998) Intact recognition of facial emotion in Parkinson’s disease. Neuropsychology 12:253–258PubMedCrossRef

Benke T, Bosch S, Andree B (1998) A study of emotional processing in Parkinson’s disease. Brain Cogn 38:36–52PubMedCrossRef

Borod JC (2000) The neuropsychology of emotion. Oxford University Press, New York

Borod JC, Welkowitz J, Alpert M, Brozgold AZ, Martin C, Peselow E, Diller L (1990) Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of tests. J Commun Disord 23:247–271PubMedCrossRef

Bradley MM, Greenwald MK, Petry MC, Lang PJ (1992) Remembering pictures: pleasure and arousal in memory. J Exp Psychol Learn Mem Cogn 18:379–390PubMedCrossRef

Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb Cortex 11:1136–1143PubMedCrossRef

CSEA (1995) The international affective picture system (IAPS; photographic slides). Center for the Study of Emotion and Attention (CSEA-NIHM), University of Florida, Gainesville

Delaveau P, Salgado-Pineda P, Wicker B, Micallef-Roll J, Blin O (2005) Effect of levodopa on healthy volunteers’ facial emotion perception: an FMRI study. Clin Neuropharmacol 28:255–261PubMedCrossRef

Delaveau P, Salgado-Pineda P, Micallef-Roll J, Blin O (2007) Amygdala activation modulated by levodopa during emotional recognition processing in healthy volunteers: a double-blind, placebo-controlled study. J Clin Psychopharmacol 27:692–697PubMedCrossRef

Fahn S, Elton R (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden MC, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information, Florham Park, pp 153–163, 293–304

Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351:2498–2508PubMedCrossRef

Frank MJ, Seeberger LC, O’Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306:1940–1943PubMedCrossRef

Gotham AM, Brown RG, Marsden CD (1988) ‘Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa. Brain 111(Pt 2):299–321PubMedCrossRef

Hall J, Harris JM, McKirdy JW, Johnstone EC, Lawrie SM (2007) Emotional memory in schizophrenia. Neuropsychologia 45:1152–1159PubMedCrossRef

Hautzinger M, Keller F, Worall H, Bailer M (1995) Beck-Depressions-Inventar (BDI). Huber, Bern

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMed

Kan Y, Kawamura M, Hasegawa Y, Mochizuki S, Nakamura K (2002) Recognition of emotion from facial, prosodic and written verbal stimuli in Parkinson’s disease. Cortex 38:623–630PubMedCrossRef

Lehrl S (1995) Mehrfachwahl–Wortschatz-Intelligenztest. MWT-B. Straube, Erlangen

Mackiewicz KL, Sarinopoulos I, Cleven KL, Nitschke JB (2006) The effect of anticipation and the specificity of sex differences for amygdala and hippocampus function in emotional memory. Proc Natl Acad Sci USA 103:14200–14205PubMedCrossRef

Mattis S (1976) Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB (eds) Geriatric psychiatry. Grune & Stratton, New York

Micallef-Roll J, Rihet P, Hasbroucq T, Possamai C, Blin O (2001) Levodopa-induced drowsiness in healthy volunteers: results of a choice reaction time test combined with a subjective evaluation of sedation. Clin Neuropharmacol 24:91–94PubMedCrossRef

Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M (1999) Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson’s disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol 45:601–610PubMedCrossRef

Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL (2006) Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 138:901–910PubMedCrossRef

Schneider F, Habel U, Volkmann J, Regel S, Kornischka J, Sturm V, Freund HJ (2003) Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease. Arch Gen Psychiatry 60:296–302PubMedCrossRef

Schultz W (1986) Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. J Neurophysiol 56:1439–1461PubMed

Sprengelmeyer R, Young AW, Mahn K, Schroeder U, Woitalla D, Buttner T, Kuhn W, Przuntek H (2003) Facial expression recognition in people with medicated and unmedicated Parkinson’s disease. Neuropsychologia 41:1047–1057PubMedCrossRef

Suzuki A, Hoshino T, Shigemasu K, Kawamura M (2006) Disgust-specific impairment of facial expression recognition in Parkinson’s disease. Brain 129:707–717PubMedCrossRef

Tessitore A, Hariri AR, Fera F, Smith WG, Chase TN, Hyde TM, Weinberger DR, Mattay VS (2002) Dopamine modulates the response of the human amygdala: a study in Parkinson’s disease. J Neurosci 22:9099–9103PubMed

Werheid K, Hoppe C, Thone A, Muller U, Mungersdorf M, von Cramon DY (2002) The adaptive digit ordering test: clinical application, reliability, and validity of a verbal working memory test. Arch Clin Neuropsychol 17:547–565PubMedCrossRef

Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572–575PubMedCrossRef

Title: Dopaminergic modulation of emotional memory in Parkinson’s disease
Authors: Thomas D. Hälbig
Ute A. Kopp
Franziska Wodarz
Joan C. Borod
Jean-Michel Gracies
Georg Ebersbach
Andreas Kupsch
Publication date: 01-08-2008
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 8/2008
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-008-0061-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dopaminergic modulation of emotional memory in Parkinson’s disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2008

Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and d-amphetamine-treated rats

A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson’s disease patients

Development of auditory sensory memory from 2 to 6 years: an MMN study

Age-dependent changes in adenosine A1 receptor distribution and density within the nucleus tractus solitarii of normotensive and hypertensive rats

The Janus-face kynurenic acid

Cortical control of gait in healthy humans: an fMRI study